...
首页> 外文期刊>Critical care medicine >Respiratory dialysis: Reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal.
【24h】

Respiratory dialysis: Reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal.

机译:呼吸透析:减少依赖于近型体外二氧化碳的机械通气。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: : Mechanical ventilation is injurious to the lung. Use of lung-protective strategies may complicate patient management, motivating a search for better lung-replacement approaches. We investigated the ability of a novel extracorporeal venovenous CO2 removal device to reduce minute ventilation while maintaining normocarbia. DESIGN: : Prospective animal study. SETTING: : Government laboratory animal intensive care unit. SUBJECTS: : Seven sedated swine. INTERVENTIONS: : Tracheostomy, volume-controlled mechanical ventilation, and 72 hrs of round-the-clock intensive care unit care. A 15-F dual-lumen catheter was inserted in the external jugular vein and connected to the Hemolung, an extracorporeal pump-driven venovenous CO2 removal device. Minute ventilation was reduced, and normocarbia (Paco2 35-45 mm Hg) maintained. Heparinization was maintained at an activated clotting time of 150-180 secs. MEASUREMENTS AND MAIN RESULTS: : Minute ventilation (L/min), CO2 removal by Hemolung (mL/min), Hemolung blood flow, O2 consumption (mL/min), CO2 production by the lung (mL/min), Paco2, and plasma-free hemoglobin (g/dL) were measured at baseline (where applicable), 2 hrs after device insertion, and every 6 hrs thereafter. Minute ventilation was reduced from 5.6 L/min at baseline to 2.6 L/min 2 hrs after device insertion and was maintained at 3 L/min until the end of the study. CO2 removal by Hemolung remained steady over 72 hrs, averaging 72 +/- 1.2 mL/min at blood flows of 447 +/- 5 mL/min. After insertion, O2 consumption did not change; CO2 production by the lung decreased by 50% and stayed at that level (p < .001). As the arterial PCO2 rose or fell, so did CO2 removal by Hemolung. Plasma-free hemoglobin did not change. CONCLUSIONS: : Venovenous CO2 removal enabled a 50% reduction in minute ventilation while maintaining normocarbia and may be an effective lung-protective adjunct to mechanical ventilation.
机译:目的::机械通风对肺有害。使用肺保护策略可能使患者管理变得复杂化,激励寻求更好的肺部替代方法。我们调查了一种新型体外型有氧CO2去除装置来减少微小通风的能力,同时保持Normocarbia。设计::潜在动物研究。环境::政府实验室动物重症监护病房。主题::七镇静猪。干预措施::气管造口术,控制机械通风,72小时的圆形重症监护单元护理。将15-F双腔导管插入外部颈静脉中并连接到血栓,体外泵驱动的悬臂CO 2去除装置。减少了微小通风,维持诺诺卡比亚(PACO2 35-45 mm Hg)。肝素化保持在150-180秒的活性凝血时间。测量和主要结果::微小通风(L / min),二氧化碳去除血浆(ml / min),血液血流,O2消耗(ml / min),CO2由肺(ml / min),paco2和在基线(如果适用),2小时后,在装置插入后2小时测量无等离子体血红蛋白(G / DL),然后每6小时。在液体插入后,从5.6L / min减少到2.6L / min 2小时的分钟通气,并在3升/分钟后保持在研究结束。通过血栓去除的CO 2保持稳定,超过72小时,在447 +/- 5ml / min的血液中平均72 +/- 1.2ml / min。插入后,O2消耗不会改变;肺部的二氧化碳生产减少了50%并停留在该水平(P <.001)。随着动脉PCO2升起或下降,二氧化碳通过灌木脱离了。无血浆血红蛋白没有改变。结论:静脉CO 2去除能量减少50%的微小通风,同时保持NOMOCARBIA,可以是有效的肺保护辅助机械通气。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号